Marino Stram & Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,171
Closed -$205K 137
2020
Q4
$205K Buy
1,171
+81
+7% +$15.1K 0.09% 121
2020
Q3
$213K Buy
+1,090
New +$182K 0.11% 104
2019
Q2
Sell
-525
Closed -$38K 598
2019
Q1
$38K Buy
525
+2
+0.4% +$142 0.03% 188
2018
Q4
$30K Buy
523
+23
+5% +$1.44K 0.03% 182
2018
Q3
$39K Hold
500
0.03% 189
2018
Q2
$33K Hold
500
0.03% 196
2018
Q1
$26K Hold
500
0.02% 223
2017
Q4
$27K Buy
+500
New +$29.2K 0.02% 227

Other funds holding SGEN

Marino Stram & Associates's SGEN Position: Q1 2021 in Review

Marino Stram & Associates sold out of Seagen Inc. Common Stock (SGEN) in Q1 2021, closing a stake of 1,171 shares — an estimated $205K sold.

Marino Stram & Associates first reported a position in SGEN in Q4 2017 and held it in 8 quarters. The position peaked at $213K in Q3 2020. 501 funds tracked by Wall St. Rank hold SGEN as of Q1 2021.

  • Marino Stram & Associates reported no remaining Seagen Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Marino Stram & Associates sold 1,171 Seagen Inc. Common Stock shares in Q1 2021, an estimated $205K.
  • Marino Stram & Associates first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Marino Stram & Associates's Seagen Inc. Common Stock position peaked at $213K in Q3 2020.
  • 501 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2021.

Based on Marino Stram & Associates's 13F filing for Q1 2021, filed 26 Apr 2021.